<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" public-private="public">
	<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>112th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>S. 1454</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20110729">July 29, 2011</action-date>
			<action-desc><sponsor name-id="S253">Mr. Durbin</sponsor> (for himself,
			 <cosponsor name-id="S136">Mr. Cochran</cosponsor>, <cosponsor name-id="S335">Mr. Brown of Massachusetts</cosponsor>,
			 <cosponsor name-id="S131">Mr. Levin</cosponsor>, <cosponsor name-id="S308">Mr.
			 Cardin</cosponsor>, <cosponsor name-id="S270">Mr. Schumer</cosponsor>, and
			 <cosponsor name-id="S051">Mr. Inouye</cosponsor>) introduced the following
			 bill; which was read twice and referred to the
			 <committee-name committee-id="SSFI00">Committee on
			 Finance</committee-name></action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To amend title XVIII of the Social Security Act to
		  provide for extended months of Medicare coverage of immunosuppressive drugs for
		  kidney transplant patients and other renal dialysis
		  provisions.</official-title>
	</form>
	<legis-body id="H79D6625E210C401DA7F2F084ADFBF8D5" style="OLC">
		<section id="H3A091B30FFB04A85A7AE19A7EE2893F7" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the
			 <quote><short-title>Comprehensive Immunosuppressive Drug
			 Coverage for Kidney Transplant Patients Act of
			 2011</short-title></quote>.</text>
		</section><section commented="no" id="H32E0B7FFE14E4CF5B13F1F5D20693AF7"><enum>2.</enum><header>Extended months
			 of coverage of immunosuppressive drugs for kidney transplant patients and other
			 renal dialysis provisions</header>
			<subsection id="HC9A139044DCD4589AE6B0F3FEE3816F7"><enum>(a)</enum><header>Medicare
			 entitlement to immunosuppressive drugs for kidney transplant
			 recipients</header>
				<paragraph id="HB2D643CB52084D47B4BBB4EF7E65F09E"><enum>(1)</enum><header>Kidney
			 transplant recipients</header><text>Section 226A(b)(2) of the Social Security
			 Act (42 U.S.C. 426–1(b)(2)) is amended by inserting <quote>(except for
			 eligibility for enrollment under part B solely for purposes of coverage of
			 immunosuppressive drugs described in section 1861(s)(2)(J))</quote> before
			 <quote>, with the thirty-sixth month</quote>.</text>
				</paragraph><paragraph id="HF49761EFDACB45678FEE0D1F58E449AD"><enum>(2)</enum><header>Individuals
			 eligible only for coverage of immunosuppressive drugs</header>
					<subparagraph id="HC30E7F7E037B4D908B08278217E3C212"><enum>(A)</enum><text>Section 1836 of
			 the Social Security Act (42 U.S.C. 1395o) is amended—</text>
						<clause id="H7CA80A4EB9A64F76A641CB14284A0050"><enum>(i)</enum><text>by
			 striking <quote>Every</quote> and inserting <quote>(a)
			 <header-in-text level="subsection" style="OLC">In
			 general</header-in-text>.—Every</quote>; and</text>
						</clause><clause id="H6912806DF6B04D3C96EAE770E19D30FE"><enum>(ii)</enum><text>by
			 inserting at the end the following new subsection:</text>
							<quoted-block display-inline="no-display-inline" id="H8E8AE0CA25AE4D6E844F187CA0EA8BE9" style="OLC">
								<subsection id="HEF3AC7F4584C4D309E4443F487931D17"><enum>(b)</enum><header>Individuals
				eligible for immunosuppressive drug coverage</header><text>Beginning on January
				1, 2012, every individual whose insurance benefits under part A have ended
				(whether before, on, or after such date) by reason of section 226A(b)(2) is
				eligible for enrollment in the insurance program established by this part
				solely for purposes of coverage of immunosuppressive
				drugs.</text>
								</subsection><after-quoted-block>.</after-quoted-block></quoted-block>
						</clause></subparagraph><subparagraph id="H079BD9D3294A46EBBAEA793B8F9652B8"><enum>(B)</enum><header>Conforming
			 amendment</header><text>Sections 1837, 1838, and 1839 of the Social Security
			 Act (42 U.S.C. 1395(p), 42 U.S.C. 1395(q), 42 U.S.C. 1395(r)) are each amended
			 by striking <quote>1836</quote> and inserting <quote>1836(a)</quote> each place
			 it appears.</text>
					</subparagraph></paragraph><paragraph id="HEAACE32DFC3F433B8C13359E2ADAE35E"><enum>(3)</enum><header>Enrollment for
			 individuals only eligible for coverage of immunosuppressive
			 drugs</header><text>Section 1837 of the Social Security Act (42 U.S.C. 1395(p))
			 is amended by adding at the end the following new subsection:</text>
					<quoted-block display-inline="no-display-inline" id="H5877B3C667684906A05F45696813AF0C" style="OLC">
						<subsection id="H981D79DA4B95412DAC00FE22FE8EBC04"><enum>(m)</enum><paragraph commented="no" display-inline="yes-display-inline" id="H7816FB2901294B28A948B450437D2405"><enum>(1)</enum><text>Any individual who is
				eligible under section 1836(b) to enroll in the medical insurance program
				established under this part for purposes of coverage of immunosuppressive drugs
				may enroll only in such manner and form as may be prescribed by regulations,
				and only during an enrollment period described in this subsection.</text>
							</paragraph><paragraph id="H0753D6EE717B44A38EE6137E11DE159F" indent="up1"><enum>(2)</enum><text>An individual described in paragraph
				(1) may enroll beginning on the first day of the third month before the month
				in which the individual first satisfies section 1836(b).</text>
							</paragraph><paragraph id="HA9ABEAD4F0B24478BDC288E6D2CB4105" indent="up1"><enum>(3)</enum><text>An individual described in paragraph
				(1) whose entitlement for hospital insurance benefits under part A ends by
				reason of section 226A(b)(2) on or after January 1, 2012, shall be deemed to
				have enrolled in the medical insurance program established by this part for
				purposes of coverage of immunosuppressive
				drugs.</text>
							</paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
				</paragraph><paragraph id="HA73EFCD543C44CF79A15ADBA39692377"><enum>(4)</enum><header>Coverage period
			 for individuals only eligible for coverage of immunosuppressive drugs</header>
					<subparagraph id="HC012907691A541D0822A2DDE27930CCB"><enum>(A)</enum><header>In
			 general</header><text>Section 1838 of the Social Security Act (42 U.S.C. 1395q)
			 is amended by adding at the end the following new subsection:</text>
						<quoted-block display-inline="no-display-inline" id="H518F6AC384EB45B2802C72F39FD2D088" style="OLC">
							<subsection id="HE2C7136954714D9AB86583DD00A9A0A5"><enum>(g)</enum><text>In the case of an
				individual described in section 1836(b), the following rules shall
				apply:</text>
								<paragraph id="HF8266E3BF6224CA5BDFAEB8AA0DC5FEB"><enum>(1)</enum><text>In the case of
				such an individual who is deemed to have enrolled in part B for coverage of
				immunosuppressive drugs under section 1837(m)(3), such individual’s coverage
				period shall begin on the first day of the month in which the individual first
				satisfies section 1836(b).</text>
								</paragraph><paragraph id="H74E98B4090D94F98AB3CF0EEE5C15A0A"><enum>(2)</enum><text>In the case of
				such an individual who enrolls in part B for coverage of immunosuppressive
				drugs under section 1837(m)(2), such individual’s coverage period shall begin
				on the first day of the month in which the individual first satisfies section
				1836(b) or the month following the month in which the individual so enrolls,
				whichever is later.</text>
								</paragraph><paragraph id="HE63554354F654E9CACC09C0A4C632220"><enum>(3)</enum><text>The provisions of
				subsections (b) and (d) shall apply with respect to an individual described in
				paragraph (1) or (2).</text>
								</paragraph><paragraph id="HDA605B93A97D4DC99777681668EBDD6F"><enum>(4)</enum><text>In addition to the
				reasons for termination under subsection (b), the coverage period of an
				individual described in paragraph (1) or (2) shall end when the individual
				becomes entitled to benefits under this title under section 226(a), 226(b), or
				226A.</text>
								</paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
					</subparagraph><subparagraph id="H50BB9B33FFC6489B9884009961487C4D"><enum>(B)</enum><header>Conforming
			 amendments</header><text>Section 1838(b) of the Social Security Act (42 U.S.C.
			 1395q(b)) is amended, in the matter following paragraph (2), by adding
			 <quote>or section 1837(m)(3)</quote> after <quote>section 1837(f)</quote> each
			 place it appears.</text>
					</subparagraph></paragraph><paragraph id="HE28EA68FA62E4C6F968EDC4B789BE252"><enum>(5)</enum><header>Premiums for
			 individuals only eligible for coverage of immunosuppressive
			 drugs</header><text>Section 1839 of the Social Security Act (42 U.S.C. 1395r)
			 is amended—</text>
					<subparagraph id="HD317B0371A8D4EB787AD9BA2552B302F"><enum>(A)</enum><text>in subsection (b),
			 by adding at the end the following new sentence: <quote>No increase in the
			 premium shall be effected for individuals who are enrolled pursuant to section
			 1836(b) for coverage only of immunosuppressive drugs.</quote>; and</text>
					</subparagraph><subparagraph id="H792E77EF565B49A7A7860C4FF78C53CF"><enum>(B)</enum><text>by adding at the
			 end the following new subsection:</text>
						<quoted-block display-inline="no-display-inline" id="H1C7B6E3924AA4839876155528C6CA490" style="OLC">
							<subsection id="H7D5F9AB0C488468382D72DBCC5F7779E"><enum>(j)</enum><header>Determination of
				premium for individuals only eligible for coverage of immunosuppressive
				drugs</header><text>The Secretary shall, during September of each year,
				determine and promulgate a monthly premium rate for the succeeding calendar
				year for individuals who enroll only for the purpose of coverage of
				immunosuppressive drugs under section 1836(b). Such premium shall be equal to
				35 percent of the monthly actuarial rate for enrollees age 65 and over,
				determined according to paragraph (1), for that succeeding calendar year. The
				monthly premium of each individual enrolled for coverage of immunosuppressive
				drugs under section 1836(b) for each month shall be the amount promulgated in
				this subsection. Such amount shall be adjusted in accordance with subsections
				(c) and
				(f).</text>
							</subsection><after-quoted-block>.</after-quoted-block></quoted-block>
					</subparagraph></paragraph><paragraph id="HF502FCCE4CB547BB987A9064F52ED866"><enum>(6)</enum><header>Government
			 contribution</header><text>Section 1844(a) of the Social Security Act (42
			 U.S.C. 1395w(a)) is amended—</text>
					<subparagraph id="H71394EB651CD4A77889D66C2003F9C0F"><enum>(A)</enum><text>in paragraph (3),
			 by striking the period at the end and inserting <quote>; plus</quote>;</text>
					</subparagraph><subparagraph id="H747E12D40A8749CB95405F3F6955DC38"><enum>(B)</enum><text>by adding at the
			 end the following new paragraph:</text>
						<quoted-block display-inline="no-display-inline" id="H53D0A3A5892D48909D5D4C30DEB72CAA" style="OLC">
							<paragraph id="H35FBC152AAAB4644B5556690C22CAFE6"><enum>(4)</enum><text display-inline="yes-display-inline">a Government contribution equal to the
				estimated aggregate reduction in premiums payable under part B that results
				from establishing the premium at 35 percent of the actuarial rate under section
				1839(j) instead of 50 percent of the actuarial rate for individuals who enroll
				only for the purpose of coverage of immunosuppressive drugs under section
				1836(b).</text>
							</paragraph><after-quoted-block>;
				and</after-quoted-block></quoted-block>
					</subparagraph><subparagraph id="H05A30E7B955948A2BC1B06791DDED70D"><enum>(C)</enum><text>by adding at the
			 end the following flush matter:</text>
						<quoted-block display-inline="no-display-inline" id="HAB5BDAECC9474A848BE27EED26047B0E" style="OLC">
							<quoted-block-continuation-text quoted-block-continuation-text-level="paragraph">The
				Government contribution under paragraph (4) shall be treated as premiums
				payable and deposited for purposes of subparagraphs (A) and (B) of paragraph
				(1).</quoted-block-continuation-text><after-quoted-block>.</after-quoted-block></quoted-block>
					</subparagraph></paragraph><paragraph id="HF72CBE8AD9CC47FB878137B09E4154F5"><enum>(7)</enum><header>Extension of
			 secondary payer requirements for ESRD beneficiaries eligible for coverage of
			 immunosuppressive drugs</header><text>Section 1862(b)(1)(C) of the Social
			 Security Act (42 U.S.C. 1395(y)(b)(1)) is amended by adding at the end the
			 following new sentence: <quote>With regard to immunosuppressive drugs furnished
			 to an individual who enrolls for the purpose of coverage of immunosuppressive
			 drugs under section 1836(b) on or after January 1, 2012, this subparagraph
			 shall apply without regard to any time limitation, except that when such
			 individual becomes entitled to benefits under this title under sections 226(a)
			 or 226(b), or entitled to or eligible for benefits under this title under
			 section 226A, the provisions of subparagraphs (A) and (B), and the time
			 limitations under this subparagraph, respectively, shall apply.</quote>.</text>
				</paragraph><paragraph id="H5B8D04A3A6DD4941870C4B7A10139E0B"><enum>(8)</enum><header>Ensuring
			 coverage under the Medicare savings program</header><text>Section 1905(p)(1)(A)
			 of the Social Security Act (42 U.S.C. 1396d(p)(1)(A)) is amended by inserting
			 <quote>or an individual who is enrolled under part B for the purpose of
			 coverage of immunosuppressive drugs under section 1836(b)</quote> after
			 <quote>section 1818</quote>.</text>
				</paragraph><paragraph id="HF0E2011316664FC0953AB930E0143E83"><enum>(9)</enum><header>Part
			 D</header><text>Section 1860D–1(a)(3)(A) of the Social Security Act (42 U.S.C.
			 1395w–101(a)(3)(A)) is amended by inserting <quote>(but not including an
			 individual enrolled solely for coverage of immunosuppressive drugs under
			 section 1836(b))</quote> before the period at the end.</text>
				</paragraph></subsection></section></legis-body>
</bill>
